Enhancing your biomarker discovery & validation
We identify and deliver the highest quality biospecimens with “MT Level” metadata for pharma R&D.
Biospecimen CRO
Enhancing your biomarker discovery & validation
We identify and deliver the highest quality biospecimens with “MT Level” metadata for pharma R&D.
20
Years Experience
150
Collection Sites
1000
of Custom Projects
The MT Group is a biospecimen CRO that seeks to improve human health by supporting pharmaceutical, biotechnology, and diagnostic companies with biospecimen products and services.
They have so much more experience in the space…my job is stressful enough, they make it easier. MT has enrolled thousands of patients for me; they are my first call when I have a biospecimen need and typically the only call.
Associate Director, Translational Development at Global Biopharma
MT Group spent the time upfront to deeply understand my study goals before putting together a thoughtful proposal. This thoroughness gave me the confidence to engage them on a first project, which has since led to several more.
Director of Clinical Affairs, Global Diagnostic Company
Biospecimen types
Fresh, Frozen & FFPE Tissue
Blood, Serum & Plasma
Swabs
Urine
Saliva
How We’re Different
Comprehensive
Clinical Annotation
We offer biospecimens with complete clinical annotation because we understand how important these metadata are in contextualizing translational research.
Quality
Guaranteed
Quality people and processes enable quality products and services. We have a high bar and stand by our work – if our biospecimens don’t meet your standards, we will replace them at no charge.
Partnerships,
Not Transactions
First time customers begin to leverage our expertise and ultimately we become true partners, which has led to the majority of our business coming from repeat clients.
News & Events
Serum vs. Plasma for Biomarker Research: A Procurement Decision Framework for R&D and Sourcing Teams
Serum and plasma are both derived from whole blood, and both are widely used in biomarker research — but they are not interchangeable. The choice between them is a scientific…
Read More Matched Healthy Controls in Translational Research: The Selection Criteria That Determine Study Validity
Healthy controls are among the most underspecified elements in translational biomarker study design. Researchers invest considerable effort defining case inclusion and exclusion criteria — tumor type, stage, treatment history, molecular…
Read More Sourcing cfDNA, ctDNA, and CTCs: A Procurement Guide for Liquid Biopsy Research Teams
Liquid biopsy has reshaped how researchers and clinicians think about tumor biology, treatment monitoring, and early cancer detection. As programs advance from discovery to clinical validation, the biospecimen sourcing decisions…
Read More 
